Compounds and methods to inhibit lpa.
CL202600832A1Pending Publication Date: 2026-07-17IONIS PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202600832
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-20
- Filing Date
- 2026-03-20
- Publication Date
- 2026-07-17
Abstract
Oligomeric duplexes, oligomeric compounds, and antisense agents, methods, and pharmaceutical compositions are provided to reduce the amount or activity of LPA RNA in a cell or animal and, in certain cases, to reduce the amount of Lp(a) in a subject. These oligomeric duplexes, oligomeric compounds, and agents, methods, and pharmaceutical compositions are useful for treating or managing inflammatory, cardiovascular, and / or metabolic diseases, disorders, or conditions.
Need to check novelty before this filing date? Find Prior Art